Sitemap
October 02, 2010 Articles
Filter by Available Specialty
- Denosumab superior to zoledronic acid for pain reduction in metastatic breast cancer
- Experts say accrual continuation needed in NSABP B-39/RTOG 0413 trial
- Oral contraceptives reduced risk for ovarian cancer
- Pathologic tumor response after neoadjuvant chemotherapy predicts risk for locoregional failure
- Second conservative treatment safe, effective in low-risk breast cancer